AmgenvsNurix Therapeutics

AMGN and NRIX stock compared: price, dividend, valuation and results, from SEC filings.

AMGN

Amgen Inc.

$465.67

Value $251B

-0.30%
AMGN's page

NRIX

Nurix Therapeutics, Inc.

$15.48

Value $1.7B

-0.77%
NRIX's page

Amgen (AMGN) has a market value of $251B and Nurix Therapeutics (NRIX) $1.7B. Over the last year, with dividends, AMGN moved +42.3% and NRIX +27.2%. The P/E is 26.7 for AMGN and 5.7 for NRIX. Dividend yield: AMGN 2.13%, NRIX none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMGN$251B

    NRIX$1.7B

    AMGN is 148 times NRIX

  • Revenue, 12 months

    AMGN$38.9B

    NRIX$702M

    AMGN is 55 times NRIX

  • Net income, 12 months

    AMGN$9.4B

    NRIX$295M

    AMGN is 32 times NRIX

  • Operating margin

    AMGN32.4%

    NRIX41.3%

    8.9 points apart

  • ROIC

    AMGN16.2%

    NRIX41.4%

    25.2 points apart

  • P/E

    AMGN26.7

    NRIX5.7

    AMGN is 4.7 times NRIX

  • Dividend yield

    AMGN2.1%

    NRIX0.0%

    2.1 points apart

  • 5-year return

    AMGN+157.4%

    NRIX-54.6%

    212.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMGN+157.4%

NRIX-54.6%

010020020222023202420252026
Returns by period
PeriodAMGNWith dividendsNRIXWith dividends
1 year since November 12, 2025+42.3%Price +38.5%+27.2%Price +27.2%
3 years since November 13, 2023+91.0%+24.1% a yearPrice +74.6%+194.3%+43.3% a yearPrice +194.3%
5 years since November 12, 2021+157.4%+20.8% a yearPrice +120.3%-54.6%-14.6% a yearPrice -54.6%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMGNAmgenNRIXNurix Therapeutics

Valuation

AMGNNRIX
Valuation
Price$465.67$15.48
Market value$251B$1.7B
Enterprise value (EV)$292B$591M
P/E26.75.7
P/E, 5-year median23.0–
P/B17.51.8
EV/EBIT23.12.0
Free cash flow yield3.8%21.9%

Results and growth

AMGNNRIX
Results and growth
Revenue, 12 months$38.9B$702M
Net income, 12 months$9.4B$295M
Free cash flow, 12 months$9.6B$370M
Earnings per share, 12 months$17.25$2.70
Revenue growth, year on year10.0%53.9%
Revenue growth a year, past+7.6%over 5 years+36.4%over 5 years
EPS growth a year, past+2.9%over 5 years–

Margins and returns on capital

AMGNNRIX
Margins and returns on capital
Gross margin70.9%–
Operating margin32.4%41.3%
Net margin24.1%42.0%
ROIC16.2%41.4%
ROE87.8%53.4%

Balance sheet

AMGNNRIX
Balance sheet
Cash$13.2B$1.1B
Total debt$54.0B$65M
Net debt / EBITDA2.3-3.7
Interest cover4.8×–

Dividends and buybacks

AMGNNRIX
Dividends and buybacks
Dividend yield2.1%–
Dividend per share, 12 months$9.94–
Dividend growth a year, past+8.1%over 5 years–
Buyback yield––
Shareholder yield2.1%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMGN or NRIX

Didn't find what you were looking for?

Ask us
Which is bigger, Amgen or Nurix Therapeutics?

By market value, Amgen ($251B) is about 148.4 times Nurix Therapeutics ($1.7B), at today's prices.

How did AMGN and NRIX stock do over the last 5 years?

Since November 12, 2021, AMGN's price moved +120.3% and NRIX's -54.6%. With dividends: AMGN +157.4% (+20.8% a year), NRIX -54.6% (-14.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMGN or NRIX?

The dividend yield at today's price is 2.13% for Amgen and none for Nurix Therapeutics. Over the last twelve months they paid $9.94 and – per share.

What is the P/E of AMGN and NRIX?

At today's price, the P/E is 26.7 for AMGN and 5.7 for NRIX. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Amgen or Nurix Therapeutics?

Over the last twelve months, the net margin was 24.1% for Amgen and 42.0% for Nurix Therapeutics, and the operating margin 32.4% and 41.3%. Revenue was $38.9B and $702M.

Which is the better investment, Amgen or Nurix Therapeutics?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.